Avdoralimab (anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FORCE)
Julien Carvelli,Ferhat Meziani,Jean Dellamonica,Pierre-Yves Cordier,Jerome Allardet-Servent, Megan Fraisse,Lionel Velly,Saber Barbar,Samuel Lehingue,Christophe Guervilly,Maxime Desgrouas,Fabrice Camou,Christelle Piperoglou,Frederic Vely,Robert Zerbib, Emmanuel Mitry,Joyson Karakunnel, Joanna Fares,Luciana Batista,Federico Rotolo,Julien Viotti,Agnès Boyer-Chammard,Sabrina Carpentier,Olivier Demaria,Karine Lacombe, Erwan Le Dault, Nassima Chouaki-Benmansour,michel Carles,Nicolas Schleinitz,Eric Vivier Social Science Research Network（2022）
AI 理解论文
溯源树
样例
